Fibroblast Activation Protein Inhibitor Market Overview

added blog Health

2026-06-20 09:26:19 -

The Fibroblast Activation Protein Inhibitor Market is experiencing robust growth, valued at $1.49 billion in 2024 and projected to reach $5.0 billion by 2032. This expansion reflects a compound annual growth rate (CAGR) of 16.33%, driven by increasing cancer prevalence and rising demand for targeted therapies. Fibroblast activation protein (FAP) inhibitors represent a promising therapeutic...

0 Comments 0 Shares 86 Views 0 Reviews